PLSE
PLSE
US74587B1017
Pulse Biosciences, Inc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 350.000 --
--
Cost of Revenue 539.000 --
--
Gross Profit -189.000 --
--
76.750.000 56.257.000
36.4%
Operating Income -76.939.000 -56.257.000
36.8%
Pretax Income -72.781.000 -53.585.000
35.8%
Net Income Common Stockholders -72.781.000 -53.585.000
35.8%
-- --
--
-- --
--
ende